Table 1.
SBA-15 nanomaterials.
| MSN | SBA-15|XN1 | SBA-15|XN2 | SBA-15|XN3 | SBA-15|IXN1 | SBA-15|IXN2 | SBA-15|IXN3 |
|---|---|---|---|---|---|---|
| Drug amount [mg] | 30 | 60 | 90 | 30 | 60 | 90 |
| Yield [mg] | 279 | 274 | 306 | 230 | 198 | 275 |
| Loading [%] | 0.9 | 2.7 | 5 | 1.1 | 2.3 | 3.5 |
| Encaps. efficiency [%] | 8 | 12 | 17 | 8 | 8 | 11 |
| Hydrodynamic r [nm] | 877 | 889 | 785 | 831 | 731 | 852 |
| BET surface [m2 g−1] | 419.99 | 525.11 | 468.26 | 403.92 | 433.1 | 426.39 |
| Vpore [cm3 g−1] | 0.5 | 0.77 | 0.72 | 0.49 | 0.45 | 0.51 |
| dpore [nm] | 3.7 | 5.9 | 5.8 | 3.7 | 3.7 | 3.7 |
| Wall thickness [nm] | 5.3 | 3.3 | 3.3 | 4.4 | 4.5 | 5.4 |
| Miller ind. 2θ [°] | 1.1034 (100) 1.4567 (111) 2.0682 (200) | 1.0035 (100) 1.6496 (111) 1.8809 (200) | 1.0083 (100) 1.6339 (111) 1.8721 (200) | 1.1261 (100) 2.1071 (200) | 1.1193 (100) 1.6496 (111) 2.0734 (200) | 1.1037 (100) 1.4191 (111) 2.0836 (200) |
| Lattice param. [nm] | 9 | 9.2 | 9.2 | 8.1 | 8.2 | 9.1 |